<bill session="113" type="h" number="1295" updated="2014-08-17T23:26:49-04:00">
  <state datetime="2013-03-20">REFERRED</state>
  <status>
    <introduced datetime="2013-03-20"/>
  </status>
  <introduced datetime="2013-03-20"/>
  <titles>
    <title type="short" as="introduced">Medical Device Tax Elimination Act</title>
    <title type="official" as="introduced">To amend the Internal Revenue Code of 1986 to repeal the excise tax on medical devices, and for other purposes.</title>
  </titles>
  <sponsor thomas_id="01943"/>
  <cosponsors>
    <cosponsor thomas_id="01888" joined="2013-10-08"/>
    <cosponsor thomas_id="02145" joined="2013-11-13"/>
    <cosponsor thomas_id="00701" joined="2013-09-30"/>
    <cosponsor thomas_id="01910" joined="2013-03-20"/>
    <cosponsor thomas_id="01884" joined="2013-04-09"/>
    <cosponsor thomas_id="01207" joined="2013-04-18"/>
  </cosponsors>
  <actions>
    <action datetime="2013-03-20" state="REFERRED">
      <text>Referred to the House Committee on Ways and Means.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
  </committees>
  <relatedbills>
    <bill type="h" session="113" relation="unknown" number="523"/>
    <bill type="h" session="113" relation="unknown" number="699"/>
    <bill type="h" session="113" relation="unknown" number="2956"/>
    <bill type="s" session="113" relation="unknown" number="232"/>
  </relatedbills>
  <subjects>
    <term name="Taxation"/>
    <term name="Accounting and auditing"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Income tax credits"/>
    <term name="Income tax deductions"/>
    <term name="Oil and gas"/>
    <term name="Sales and excise taxes"/>
    <term name="Tax administration and collection, taxpayers"/>
    <term name="Taxation of foreign income"/>
  </subjects>
  <amendments/>
  <summary>3/20/2013--Introduced.
Medical Device Tax Elimination Act - Amends the Internal Revenue Code to: (1) repeal the excise tax on medical devices; (2) deny major integrated oil companies (companies which have an average daily worldwide annual production of crude oil of at least 500,000 barrels and annual gross receipts in excess of $1 billion) the tax deduction for income attributable to oil, natural gas, or primary products thereof; (3) prohibit the use of the last-in, first-out (LIFO) accounting method by major integrated oil companies; and (4) deny the foreign tax credit to major integrated oil companies that are dual taxpayers (companies that receive an economic benefit from a foreign country or a possession of the United States that does not impose a generally applicable income tax).</summary>
</bill>
